H.I.G. Capital, a prominent global investment firm, is making significant strides in the healthcare industry and adjacent sectors. With a robust portfolio under management, the firm is strategically positioning itself to capitalize on emerging opportunities in these markets.

In a notable move, H.I.G. Capital acquired SkinCure Oncology, a leader in image-guided superficial radiation therapy (IG-SRT) for nonmelanoma skin cancer. This acquisition underscores H.I.G. Capital’s commitment to advancing non-invasive cancer treatment technologies. SkinCure Oncology has treated over 100,000 patients nationwide, highlighting the potential impact of this strategic purchase.

Another significant transaction involved the sale of BIOVECTRA, a contract development and manufacturing organization (CDMO). Sold to Agilent Technologies for $925 million, this deal exemplifies H.I.G. Capital’s ability to elevate companies under its ownership, driving growth and innovation.

In July, H.I.G. Capital expanded its reach into the organic products market by acquiring a majority stake in Naturalia Tantum, an Italian company renowned for its organic beauty and personal care products. This acquisition reflects the firm’s interest in the burgeoning demand for natural consumer goods.

H.I.G. Capital’s investments are not limited to direct healthcare sectors. The firm’s acquisition of Action Elevator, a company providing maintenance and repair services for elevators, highlights its interest in supporting industries vital to healthcare infrastructure. This strategic buy expands H.I.G.’s presence in the Mid-Atlantic region.

These moves demonstrate H.I.G. Capital’s strategic approach to diversify its investments, focusing on sectors with strong growth trajectories. By targeting innovative healthcare solutions and supporting infrastructure, H.I.G. Capital is poised to make a lasting impact across various industries.